Delivery Order SPE2DB22D3501-SPE2DB23FWY20

Award Date 8/21/23
Potential Completion Date 8/22/23
Potential Value $582
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $1,050.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for COMBIPATCH 0.05-0.14 MG PTCH 8S. The order is to be performed by Amerisourcebergen's Conshohocken, Pennsylvania facility over the period of August 8-9, 2023. As the DLA is responsible for procuring medical supplies and pharmaceuticals for the U.S. military and other government agencies, this order is likely to deliver transdermal combination hormone replacement patches for...
The Defense Logistics Agency awarded a $985 firm fixed price delivery order to Amerisourcebergen Drug Corporation for COMBIPATCH transdermal patches. The patches will be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania under a one-day period of performance from August 16-17, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing indefinite-delivery/indefinite-quantity contract vehicle....
The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred five thousand dollars and eight cents ($105,008) to Amerisourcebergen Drug Corporation for the supply of eight (8) Combipatch transdermal patches in 0.05-0.14 mg dosage. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from August 23 to August 24, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense,...
The Defense Logistics Agency Troop Support Medical awarded a $550,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562252100 COMBIPATCH 0.05-0.14 MG PTCH 8S. The order was placed under an existing prime vendor contract vehicle to supply transdermal combination hormone therapy patches to DLA medical treatment facilities. Performance will occur at Amerisourcebergen's distribution center in Conshohocken, Pennsylvania over a one day period from September 20th through...
The Defense Logistics Agency awarded a $630 delivery order to Amerisourcebergen Drug Corporation for COMBIPATCH transdermal patches. Under this firm fixed price contract, Amerisourcebergen will provide approximately 630,000 dollars worth of COMBIPATCH 0.05-0.14 mg transdermal patches to the DLA. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three day period in mid-August 2023. No subcontractors or set aside designations were identified. This...
The Defense Logistics Agency Troop Support Medical awarded a $428,120 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561412449 COMBIPATCH 0.05-0.14 MG PTCH 8S. The place of performance is Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. The delivery order has a period of performance from July 5, 2023 through July 6, 2023 to supply transdermal combination hormone patches for the Department of Defense. No major subcontractors or set aside designations...
The Defense Logistics Agency awarded a $198,480 firm fixed price delivery order to Amerisourcebergen Drug Corporation for COMBIPATCH transdermal patches. The patches will be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania under a one-day period of performance from July 18-19, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for transdermal medication patches supports the Defense Logistics Agency's mission to...
The Defense Logistics Agency awarded a $745.31 firm fixed price delivery order to Amerisourcebergen Drug Corporation for COMBIPATCH transdermal patches. As the prime contractor, Amerisourcebergen will deliver the medication to the DLA under a one-day period of performance beginning July 10th and concluding on July 11th, 2023. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. No subcontractors or set aside designations were indicated. This order is likely...
The Defense Logistics Agency awarded a $630 delivery order to Amerisourcebergen Drug Corporation for COMBIPATCH transdermal patches. As the prime contractor, Amerisourcebergen will supply 8 boxes of the 0.05-0.14 mg dosage patches to fulfill requirements under the agency's pharmaceutical products contract vehicle. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period from August 7-8, 2023. The firm fixed price contract has no set aside...
Defense Logistics Agency awarded a $287 firm fixed price delivery order to Amerisourcebergen Drug Corp for COMBIPATCH 0.05-0.25 MG PTCH 8S. The order is under the corporate vendor's indefinite-delivery/indefinite-quantity pharmaceutical prime vendor contract and has a period of performance through October 2023. Place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania. No set-aside designation was used for this order to supply transdermal combination hormone patches...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB23FWY20
    Delivery Order

The Defense Logistics Agency awarded a $581,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for COMBIPATCH transdermal patches. Under this single day contract, Amerisourcebergen will supply 8,000 boxes of the 0.05-0.25 mg dosage patches to a Conshohocken, Pennsylvania facility from August 21-22, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for the combination estrogen and progestin patches supports the DLA's mission to provide optimal healthcare support to military members.

Generated 12/24/23, 3:40 AM